New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For UBS;FLO;GSK;NOK;SI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
October 20, 2014
09:09 EDTGSKEMA encourages applications for orphan designation for Ebola treatments
The European Medicines Agency encourages developers of treatments or vaccines against Ebola to apply for orphan designation. Applications for orphan designation of Ebola medicines will be treated as a priority and EMA has committed to fast-tracking their evaluation, the regulator announced. Drug companies that are working on experimental Ebola vaccines and treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX), NewLink Genetics (NLNK) and GlaxoSmithKline (GSK).
07:21 EDTUBSFederal Reserve Bank of New York and Boston to hold a workshop
Subscribe for More Information
07:19 EDTGSKIBC Life Sciences to hold a conference
Subscribe for More Information
07:12 EDTSICongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
07:11 EDTSIAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
October 19, 2014
14:03 EDTUBSUBS stays with risky Puerto Rico bond fund recommendations, Reuters says
Despite numerous arbitration claims by investors who cite Puerto Rico closed-end bond funds for losses, UBS has told brokers that they may continue to recommend the funds, says Reuters. Reference Link
October 17, 2014
14:50 EDTGSKBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
11:17 EDTGSKGSK says Ebola vaccine too late for current epidemic, BBC reports
Subscribe for More Information
October 16, 2014
08:42 EDTUBSUBS, DOJ in talks for forex rigging settlement, FT reports
Subscribe for More Information
06:50 EDTUBSEuropean regulator rejects bonus loophole, NY Times says
Subscribe for More Information
October 15, 2014
07:27 EDTUBSJPMorgan, HSBC fire traders linked to forex probe, WSJ reports
Subscribe for More Information
October 14, 2014
13:09 EDTGSKGlaxoSmithKline seeks binding bids for mature drugs, Reuters reports
Subscribe for More Information
11:23 EDTGSKBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTGSKNIH says several potential Ebola treatments under development
Subscribe for More Information
10:10 EDTGSKNIH director says supporting BioCryst, Chimerix Ebola treatments
Subscribe for More Information
October 13, 2014
07:12 EDTGSKOligonucleotide Therapeutics Society to hold annual meeting
Subscribe for More Information
October 10, 2014
10:15 EDTNOKNokia, China Mobile sign framework agreement valued at $970M
Subscribe for More Information
09:13 EDTUBSEBA says EU stress test results to be published October 26
Subscribe for More Information
October 9, 2014
07:13 EDTNOKNokia reinstated with a Buy at BofA/Merrill
07:02 EDTGSKIsis Pharmaceuticals receives $18M milestone payment from GlaxoSmithKline
Subscribe for More Information
October 8, 2014
07:36 EDTUBSPeterson Institute for International Economics to hold a discussion
Board of Directors Chairman of UBS AG, Axel Weber, discusses whether the global economy can heal and if inflation will make a comeback in 2015 in a webcast being held on October 8 at 12:15 pm. Webcast Link
06:11 EDTGSKNovartis says expects three executive committee members to leave
Novartis (NVS) confirmed that following completion of the transactions with GlaxoSmithKline (GSK) and Eli Lilly and Company (LLY) in the coming months, that the three business leaders of the Novartis divisions at the center of the transaction will leave the Executive Committee of Novartis. The expected changes to the ECN are subject to the closing of the transactions announced on April 22 - Novartis expects the transaction with GSK to be completed in the first half of 2015, and the transaction with Eli Lilly for its Animal Health Business to close in the first quarter of 2015. George Gunn, currently Division Head, Novartis Animal Health, will reach his contractual retirement age in July 2015 and will retire from Novartis. Upon closing of the Animal Health transaction with Lilly he will leave the ECN. Brian McNamara, currently Division Head, Novartis OTC, will transition to GSK as Head of Americas and Europe for the consumer health businesses, reporting to the President of GSK Consumer Healthcare, effective at closing of the transaction. Andrin Oswald, currently Division Head, Novartis Vaccines, will be leaving Novartis to pursue other opportunities following closing of the transaction with GSK.
October 7, 2014
10:52 EDTNOKNokia suspends handset production at Chennai facility, Reuters reports
Subscribe for More Information
06:51 EDTUBSJustice Department set to attack more large banks by year end, NY Times says
Subscribe for More Information
06:40 EDTUBSUBS French division aims to restructure asset management unit, Reuters says
The French division of UBS is aiming to reorganize its asset management unit and is in discussion with unions regarding potential staff reductions, as the bank looks to concentrate on private banking, according to Reuters, citing a spokeswoman for UBS France. Reference Link
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use